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Abstract: Nucleic acid (NA) extraction is a basic step for genetic analysis, from scientific research to
diagnostic and forensic applications. It aims at preparing samples for its application with biomolecu-
lar technologies such as isothermal and non-isothermal amplification, hybridization, electrophoresis,
Sanger sequencing and next-generation sequencing. Multiple steps are involved in NA collection
from raw samples, including cell separation from the rest of the specimen, cell lysis, NA isolation and
release. Typically, this process needs molecular biology facilities, specialized instrumentation and
labor-intensive operations. Microfluidic devices have been developed to analyze NA samples with
high efficacy and sensitivity. In this context, the integration within the chip of the sample preparation
phase is crucial to leverage the promise of portable, fast, user-friendly and economic point-of-care
solutions. This review presents an overview of existing lab-on-a-chip (LOC) solutions designed to
provide automated NA extraction from human raw biological fluids, such as whole blood, excreta
(urine and feces), saliva. It mainly focuses on LOC implementation aspects, aiming to describe a
detailed panorama of strategies implemented for different human raw sample preparations.
Keywords: lab-on-chip; LOC; nucleic acid extraction; microfluidics; solid-phase extraction; SPE
1. Introduction
Nucleic acid (NA) diagnostics, often called molecular diagnostics, consist of measuring
DNA or RNA to evaluate the presence of pathological conditions, such as genetic dysreg-
ulations or invading pathogens. Most of the developed techniques in this field include a
nucleic acid amplification step (commonly enabled through polymerase chain reaction—
PCR—or loop amplification mediated polymorphism—LAMP—methods), which relies
on nucleic acid extraction from samples [1]. Traditional NA diagnostics require access to
suitable laboratories, equipped with bulky and expensive instrumentation that typically
requires skilled personnel to be operated.
One of the objectives in current biotechnological research consists of developing
molecular diagnostic tools easy to use, needing low amounts of samples, and possibly not
requiring fully equipped labs to be operated. The concept of ‘lab-on-a-chip’ (LOC) goes
towards this direction. The term LOC refers to a class of devices combining one or multiple
biomolecular steps, typically handled in equipped laboratories, within a single minia-
turized system, based on integrated microfluidic circuits. LOC enabling technologies
include microfluidics [2], microelectronics [3], photolithography and other fabrication
techniques [4], chemical or physical methods for cell lysis [5] and for NA purification [6,7].
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The small dimension of such tools brings numerous advantages: (1) cost efficiency,
directly derived from small size, which intrinsically reduces reagents and samples volumes;
(2) automation, due to a self-standing experimental pipeline not needing human inter-
vention; (3) diagnostic speed, directly related to automated performance of lab activities
and reduced volumes; (4) ease of use, also deriving from LOC automation, which should
simplify laboratory processes; (5) portability, enabled by the small size of the device and the
absence of most of constraints related to an equipped laboratory; (6) reaction robustness,
because an enclosed ‘sample-in answer-out’ system reduces the risk of cross-contamination,
preserves NA purity and stability and enhances results reproducibility; (7) workers’ safety
enhancement, avoiding direct contact with potentially toxic molecules [8–11].
LOCs have been designed to accomplish many biomolecular analyses, including
nucleic acid extraction from raw samples, such as whole blood, urine, saliva, stool, thus
fostering the shift of NA diagnostics from traditional laboratory tests to rapid tests, exter-
nalized to the point-of-care (POC), that allow distribution of NA diagnostics over a larger
territory, to facilitate the access in remote areas and from impaired patients [12].
A functional and efficient POC platform, as well as a portable device for any biomolec-
ular investigation, must be equipped with an autonomous sample preparation method,
which critically impacts the efficiency and usability of the downstream assay. Despite
the NA extraction phase from raw samples is important to enable a full POC proce-
dure, this step has been rarely considered in the translation from lab practices to LOC
approaches [13,14].
LOCs, POC tests and microfluidic systems are recurrent topics in technology advance-
ment, and these concepts have been widely treated in the literature. Recent examples
include the following: Ayoib et al. [15] and Reinholt et al. [16], who focus on the most
common NA isolation techniques; Park et al. [17], who provide a detailed explanation of
chip structures and sample motion strategies; Jayamohan et al. [2], who describe the most
recurrent post-processing techniques; Kong et al. [18], who provide details regarding pro-
duction and use of lab-on-a-disk (LOD) systems; Xu et al. [19], who describe microfluidic
approaches to isolate cell-free DNA; Cui et al. [20], who summarize the major microflu-
idic techniques for preparation of clinically relevant samples (whole blood, urine, saliva);
Bruijns et al. [21], who describe forensic applications of LOCs. Nevertheless, an exhaustive
overview of NA extraction approaches from human raw samples enabled on LOCs can be
useful for scientists approaching the POC theme. In this context, the present review pro-
poses a critical overview of existing microfluidic devices that automate NA extraction from
raw human samples, which includes the choices of the NA capture method (isolation) and
of a suitable chip design, along with pre-treatment (cell lysis) and post-processing (purifica-
tion) strategies. The NA extraction stage is a key component of integrated portable systems,
and it massively impacts the effectiveness of successive steps of molecular diagnostics.
2. Microfluidic Systems for NA Extraction
Although many different LOCs have been developed in the last decades to perform
this step, recurrent building schemes exist (Figure 1). The sample preparation pipeline
includes different steps such as cell sorting, isolation and lysis, nucleic acids separation
and collection.
The diverse physical and chemical composition of the possible biospecimens (i.e.,
whole blood, urine, saliva, stool, etc.) does not allow for a universal separation module
to be designed. Therefore, this review is organized on the basis of the different kinds
of samples being fed to the device, rather than on the chemical/physical approach the
extraction technology relies on, and on the extracted NA type.




Figure 1. Theoretical scheme of a LOC for NA extraction from raw human samples. Raw samples 
are filtered, if necessary, and cells are lysed. NA are captured while other cellular components are 
removed. The successive step involves NA elution to obtain pure NA, which can be analyzed online 
or withdrawn for offline analyses. 
Some of the described LOCs are developed with the only purpose of extracting NA 
for further analyses, while others are coupled with a subsequent amplification or detec-
tion steps in a continuous system. In this review, both of these LOC categories are consid-
ered, because the aim is to highlight methods for NA extraction useful for improving au-
tomation of existing amplification devices. Fostering the idea of POC, only LOCs for NA 
extraction from crude biological samplings are considered. A high number of automated, 
portable tools have been developed for extracting NA from whole blood. In fact, this bio-
logical sample, being usually taken from venous blood draw—but also easily with a fin-
gerstick—is easily available especially for clinical analyses involving genomic or circulat-
ing DNA, or for investigating bacterial contaminations. Nevertheless, most of the devices 
initially developed for whole blood showed the capability of extracting NA even from 
other biological raw samples such as saliva, urine, semen, nasal swab, or spinal fluid. 
Different solutions for NA extraction have been implemented in order to propose 
novel approaches and to obtain improved LOC performances in terms of shortening ex-
traction time (while guaranteeing a reliable process) and reducing the need for large sam-
ple volumes (preserving the achievement of adequate NA concentration). A summary of 
these aspects is presented in Table 1, which lists characteristics of the LOCs presented in 
this review. 
Considering the whole process from raw sample loading to NA collection, the de-
scribed extraction times span from 7 to 50 minutes. Highly straightforward methods were 
proposed for NA extraction from blood and blood serum, presenting a purification time 
of about 1 minute. Although, depending on the extraction matrix properties and tech-
niques, the minimum starting material needed for enabling NA successful extraction in 
LOCs is very small for whole blood (90 nL in Hung et al. [22]), serum (0.4 µL in Lee et al. 
[23]) and semen (1 µL in Bienvenue et al. [24]), while higher volumes appear to be needed 
for NA extraction from saliva (at least 10 µL in Legendre et al. [25]), urine (at least 50 µL 
in Han et al. [26]), or stool (at least 200 mg in Kang et al. [27]). Other considerations on 
reported features are discussed further in the text. 
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removed. The successive step involves NA elution to obtain pure NA, which can be analyzed online
or withdrawn for offline analyses.
Some of the described LOCs are developed with the only purpose of extracting NA
for further analyses, while others are coupled with a subsequent amplification or detection
steps in a continuous system. In this review, both of these LOC categories are considered,
because the aim is to highlight methods for NA extraction useful for improving automation
of existing amplification devices. Fostering the idea of POC, only L Cs for NA extraction
from crude biological samplings are considered. A high number of automated, portable
tools have been developed for extracting NA from whole blood. In fact, this biological
sample, being usually taken from venous blood draw—but also easily with a fingerstick—
is easily avail ble especially for linical analyses involving genomic or circulating DNA,
or for investigati g bacterial contaminations. Nevertheless, most of the devices initially
developed for whole blood showed the capability of extracting NA even from other
biologica raw samples such as saliva, urine, sem n, nasal swab, or spinal fluid.
r c es and to obtain improved LOC performances in terms of shortening
extraction time (while guaranteeing a re iable process) an reducing the need for large
sample volumes (preserving the achiev ment of adequate NA concen ration). A su mary
of these aspect is pr sented in Table 1, which lists characteristics of t e
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ro ose for extraction from blood and blood serum, presenting a purification time of
about 1 minute. Although, depending on the extraction matrix properties and techniques,
the minimu starting material needed for enabling NA successful extraction in LOCs is
very small for whole blood (90 nL in Hung et al. [22]), serum (0.4 µL in Lee et al. [23])
and semen (1 µL in Bienvenue et al. [24]), while higher volumes appear to be needed for
NA extraction from saliva (at least 10 µL in Legendre et al. [25]), urine (at least 50 µL
in Han et al. [26]), or stool (at least 200 mg in Kang et al. [27]). Other considerations on
reported features are discussed further in the text.
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Table 1. Summary of the performances for considered LOCs. Type and volume of starting biological sample, on- or off-chip




NA Yield/Limits of Detection
(in Eluted Volume)
Extraction Matrix
and Motion Principles Ref
Whole blood 200 µL 30 min On Total NA,∼105 DNA copies (in 100 µL)
Silica-coated magnetic beads,
magnetic and centrifugal-driven [28]
Whole blood 1 µL 7–8 min On Genomic DNA,21.8 ± 2.3 ng/µL
Glass fiber filter,
pressure-driven [29]
Whole blood 0.1–100 µL 1 min Off Human mRNAYield n.a.
Oligo-dT magnetic beads,
lateral magnetophoresis [30]
Whole blood 10 µL <20 min On Genomic DNA,39.7 ng/µL (in 60 µL)
Porous silicon wafer,
pressure-driven [31]
Whole blood 1 µL n.a. On Pathogen DNAYield n.a.
Isotachophoresis,
electrokinetic-driven [32]
Whole blood 50 µL <60 min Off Genomic DNAYield n.a.
Silica micropillars,
pressure-driven [33]
Whole blood 5.4 µL <30 min On Pathogen DNA,∼30 ng/µL (in 25 µL)
Magnetic beads,
magnetic-driven [34]
Whole blood 200 µL 20 min On Genomic DNA,33.26 ± 2.5 ng/µL (in 5 µL)
Antibody-coated magnetic
beads, pressure-driven [35]
Whole blood 300 µL 27 min On Genomic DNA,54.3 ng/µL (in 200 µL)
Glass fiber filter,
centrifugal-driven [36]
Whole blood 20 µL <10 min Off Genomic DNA,38.8 ng/µL (in 25 µL)
Aluminium oxide membrane,
pressure-driven [37]
Whole blood 10 µL n.a. Off Genomic DNA,24 ± 0.2 ng/µL (in 2 µL)




Whole blood 1 µL n.a. On Genomic DNA,10 ng/µL (in 70 µL)
Silica monolith,
pressure-driven [39]
Whole blood 100 µL 23 min Off Pathogen RNA,LoD 103–106 copies/mL (in 100 µL)
Glass fiber filter,
capillary absorption [40]





Whole blood 0.09 µL n.a. On Genomic DNAYield n.a.
Magnetic beads,
electrokinetic-driven [22]
Whole blood 5 µL 50 min On Genomic DNA,35.7 ng/µL (in 35 µL)
Porous silicon wafer,
pressure-driven [42]
Whole blood 4 µL 9–30 min Off Genomic DNAYield n.a.
Sol-gel packed with silica beads,
pressure-driven [25]
Whole blood 10 µL <30 min Off Genomic DNA,∼9.8 ng (in 70 µL)
Sol-gel packed with silica beads,
pressure-driven [43]
Whole blood 4 µL <10 min Off Total DNAYield n.a.
Surface packed with silica beads,
pressure-driven [44]
Whole blood 5 µL 10 min Off Genomic DNA,48.7 ng (in 28 µL)
Chitosan-coated surface,
pressure-driven [45]
Whole blood 0.5 µL 20 min On Genomic DNA,19.3 ± 4.9 ng/µL (in 100 µL)
Chitosan-coated glass fiber filter,
pressure-driven [46]
Whole blood n.a. <5 min Off Total RNAYield n.a.
Glass fiber filter,
pressure-driven [47]





NA Yield/Limits of Detection
(in Eluted Volume)
Extraction Matrix
and Motion Principles Ref
Whole blood 50 µL 1 min Off Human mRNAYield n.a.
Oligo-dT magnetic beads,
magnetic-driven [48]
Whole blood 1 µL 40 min Off Genomic DNA,8 ng/µL
Magnetic beads,
magnetic-driven [49]
Whole blood 5 µL 5 min On Pathogen NA,16–35 ng/µL (in 20 µL)
Magnetic beads,
magnetic-driven [50]
Whole blood 4 mL <15 min On cfDNAYield n.a.
Silica-coated magnetic beads,
centrifugal-driven [51]





Whole blood 10 µL n.a. On Pathogen DNA,LoD 100 CFU/mL
Glass fiber filter,
centrifugal-driven [53]
Whole blood 500 µL 15 min On Pathogen DNA,100 copies/mL
Magnetic beads,
magnetic and centrifugal-driven [54]
Whole blood 30 µL 2 min On Pathogen DNA,10.000 copies/mL
Glass fiber filter,
capillary absorption [55]
Whole blood 20 µL 3 min On Pathogen DNAYield n.a.
Glass fiber filter,
capillary absorption [56]
Whole blood 25–100 µL 20 min Off Total RNA,∼250–450 ng (in 10 µL)
Magnetic beads,
electrokinetic-driven [57]
Plasma 140 µL <30 min On Total NA,∼40 ng/µL (in 20 µL)
DMP and APTES-coated surface,
pressure-driven [58]
Plasma 500 µL 15 min / cfDNA,10–100 ng/µL
Glass fiber filter,
pressure-driven [59]
Serum 30 µL 2 min On Pathogen DNA,10.000 copies/mL
Glass fiber filter,
capillary absorption [55]
Serum 200 µL <10 min On Pathogen DNA,LoD 8 copies/reaction
Silica-coated magnetic beads,
centrifugal-driven [60]
Serum 50 µL 1 min On Pathogen NA,LoD 1000 copies/mL
Magnetic beads,
magnetic and pressure-driven [61]
Serum n.a. 30 min Off Pathogen DNAYield n.a.
Poly-DMAMS-coated surface,
chemical adsorption [62]
Serum 100 µL n.a. On Pathogen DNAYield n.a.
Magnetic beads,
automatic pipetting [63]
Serum 200 µL 30 min On Pathogen DNAYield n.a.
Silica-coated magnetic beads,
magnetic and centrifugal-driven [64]
Serum 0.4 µL <1 min On Pathogen DNAYield n.a.
Carboxyl magnetic beads,
magnetic-driven [23]
Buccal sample 500 µL 7–8 min On Genomic DNAYield n.a.
Glass fiber filter,
pressure-driven [29]
Buccal sample 20 µL n.a. On Genomic DNA,4.03 ± 0.6 ng/µL
Silica-based monolith,
electrokinetic-driven [65]
Buccal sample 100 µL n.a. On Pathogen NA,LoD 103 cells-virions/mL
Glass fiber filter,
pressure-driven [66]
Buccal sample 100 µL 10 min On Genomic DNA,50.45 ng/µL (in 125 µL)
Silica-coated magnetic beads,
pressure-driven [67]





NA Yield/Limits of Detection
(in Eluted Volume)
Extraction Matrix
and Motion Principles Ref
Buccal sample 10 µL 9–30 min Off
Genomic DNA
Yield n.a.
Sol-gel packed with silica beads,
pressure-driven [25]
Buccal sample 20 µL 3 min On Pathogen DNAYield n.a.
Glass fiber filter,
capillary absorption [56]
Buccal sample 100 µL n.a. On Pathogen DNAYield n.a.
Magnetic beads,
automatic pipetting [63]
Nasal sample 30 µL 2 min On Pathogen DNA,10.000 copies/mL
Glass fiber filter,
capillary absorption [55]
Nasal sample 50 µL n.a. On Pathogen DNA,LoD 1000 CFU/mL
Glass fiber filter,
centrifugal-driven [53]
Nasal sample 1 mL <20 min On Pathogen DNA,LoD ∼61 CFU/mL
Surface packed with silica beads,
pressure-driven [68]
Nasal sample 100 µL n.a. Off Pathogen RNA,LoD 103 copies/mL
Silica-based monolith,
pressure-driven [69]
Nasal sample 30 µL 15 min Off Pathogen RNAYield n.a.
Silica-coated magnetic beads,
powerless magnetic-driven [70]
Nasal sample 500 µL n.a. On Pathogen RNAYield n.a.
Silica-coated magnetic beads,
magnetic and centrifugal-driven [71]
Nasal sample 8 µL <10 min Off Pathogen DNAYield n.a.
Surface packed with silica beads,
pressure-driven [44]
Nasal sample 10 µL 9–30 min Off
Pathogen DNA
Yield n.a.
Sol-gel packed with silica beads,
pressure-driven [25]
Nasal sample 100 µL n.a. On Pathogen NAYield n.a.
Glass fiber filter,
pressure-driven [72]
Stools 200 mg <40 min On
Pathogen NA,
46.4 ng/µL of RNA (in 200 µL)
68.4 ng/µL of DNA (in 200 µL)
Magnetic beads,
pressure-driven [27]
Stools 400 µL 7 min On Pathogen DNA,59.3 ng/µL (in 10 µL)
Silica-coated magnetic particles,
electromagnetic-driven [73]















Urine 20 µL 3 min On Pathogen DNAYield n.a.
Glass fiber filter,
capillary absorption [56]
Urine 100 µL <40 min On Pathogen DNA,LoD∼10 CFU/mL
Porous polymer monolith
packed with silica beads,
pressure-driven
[75]
Semen 2 µL n.a. On Genomic NAYield n.a.
Surface packed with beads
(silica + chitosan-coated silica),
pressure-driven
[9]





NA Yield/Limits of Detection
(in Eluted Volume)
Extraction Matrix
and Motion Principles Ref
Semen 4 µL 16 min Off Total RNAYield n.a.
Surface packed with silica beads,
pressure-driven [10]
Semen 1 µL n.a. On Genomic DNAYield n.a.
Sol-gel packed with silica beads,
pressure-driven [24]
Semen 5 µL 9–30 min Off
Genomic DNA
Yield n.a.
Sol-gel packed with silica beads,
pressure-driven [25]
Semen 1.5 µL 17 min Off Genomic DNA,17 ng (in 15 µL)
Surface packed with silica beads,
pressure-driven [76]
Spinal Fluid 40 µL <30 min Off Genomic DNAYield n.a.
Sol-gel packed with silica beads,
pressure-driven [43]
2.1. Microfluidic Circuits and Chip Structures
A crucial aspect in LOC development is chip structure. In general, an ideal solid
surface made of a variable number of layers of elastomers, polymers, silicon or composite-
glass is modeled with a pathway of microchannels and microchambers using different
fabrication techniques, like micromachining, chemical etching, molding, embossing, laser
ablation, soft lithography, and photolithography [77].
These systems of channels and chambers can be organized in domains or modules,
each for a precise processing step of the sample in its fluidic circulation (Figure 2).
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simplified scheme of Figure 1 and detailed in the schematized reconstruction of Figure 2: 
the sample is introduced through an inlet hole; a lysis step inside an inlet chamber or in a 
dedicated lysis module occurs (whenever not performed by a simple offline procedure); 
NA are captured into an extraction domain in which washing-elution phases take place, 
ending with the extract withdrawal through an outlet port (whenever automatic amplifi-
cation does not occur). Generally, wastes are collected in a specific region of the chip. 
Figure 2. Schematization of chip structures from a simpler to a more complex design. (A) Chip with a simple linear structure:
the main flux circulation is driven into a single microchannel through an inlet and an outlet port. The extraction domain
consists of a part of microchannel with a packed adsorbent matrix polymerized inside it [10,23,24,46,75]. (B) Chip with a
coil-shaped microchannel: the extraction domain is composed of a long microchannel with an increased surface/volume
ratio of the adsorbent matrix packed inside it [31,42,61,69]. (C) hip with a main i l and a side arm: sample
and reagents are loaded in se teps through diff rent ports. Flux d rection can be mo ulated at each phase by
pressure application [9,25,33,37,76]. (D) Chip with electrokinetic motion: sample and pre-stored reagents are driven by
voltage modulation into the extraction and amplification domains [65]. (E) Chip with a multi-domain design: each step
of the sample processing is managed by valve activation. Generally, complex chips allow a whole sample treatment,
from the lysis, the NA extraction with the development of various extraction techniques and, in some cases, the sample
post-proc ssing [27,35,39,44,47,66,67,71]. I = Sample or reagents inlet; O = Sample outlet; SPE = Solid-phase extraction
domain; W = Waste chamber; PCR = Amplification chamber; E = Electrodes; V = Valves; M = Mixing or lysis chamber.
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Microfluidics—defined as the use of micrometer scale channels to manipulate and
process low volumes (10−9 to 10−18 L) of fluid samples [78]—is a crucial concept in LOC
development. Microfluidic strategy consists in the controlled passage of fluids through the
microchannels patterned on the chip, enabling the sample to be transferred from the inlet
port to the elution chamber, passing through capture and collection steps. Moving through
LOCs, fluids are suitably directed, mixed, separated or manipulated to attain the desired
automated steps. The network of microchannels incorporated into the chip is connected
to the external environment by drilled holes of different size; through these pathways,
samples are injected into and evacuated from the microfluidic chip.
Typically, LOCs for NA extraction rely on a structure that can be represented in the
simplified scheme of Figure 1 and detailed in the schematized reconstruction of Figure 2:
the sample is introduced through an inlet hole; a lysis step inside an inlet chamber or in a
dedicated lysis module occurs (whenever not performed by a simple offline procedure); NA
are captured into an extraction domain in which washing-elution phases take place, ending
with the extract withdrawal through an outlet port (whenever automatic amplification
does not occur). Generally, wastes are collected in a specific region of the chip. Sometimes,
in case of RNA extraction, there is a dedicated cDNA retrotranscription chamber. Some of
these steps can be performed either online (on-chip) or offline (off-chip), depending on aim
and structure of the LOC, while others represent the core of the NA extraction process and
are performed on-chip.
The choice of the chip structure is a basic step and should be related to the sample
type and the extraction protocol, reflecting the overall function of the LOC. Typically, low-
complexity samples (e.g., urine, saliva) are processed by chips relying on packed adsorbent
matrices, or functionalized surfaces or filtering units, which are designed with a single,
long microchannel, filled with the capturing material. In case reagents are pre-loaded on a
chip, a single inlet port for sample loading could be sufficient; otherwise, multiple ports
should be considered when designing the chip structure. This second design is usually
coupled with automatic pump systems for fluids motion, while in the first case a manual
syringe could be sufficient. The mixing capacity of the system is a relevant issue to consider
when designing a LOC structure, because absence of turbulence (such as in the simplest
chips) implies passive diffusion mixing [79]; chips with side channels (forming T junctions)
or long coil-shaped microchannels [31] represent optimal strategies to obtain an adequate
passive mixing. Coil-shaped channels are also good choices to increase the surface/volume
ratio of the adsorbent region, thus increasing the extracted NA quantity. This design also
increases the total volume capacity, enabling processing of higher volumes of raw samples.
Typically, chip design includes chambers when extraction protocols need a separated
compartmentalization (as in the case of on-chip lysis, or when a strong active mixing is
necessary, or when NA are extracted with specific approaches, such as magnetic beads). A
design with chambers is also required when successive steps of NA usage are included on
a chip (e.g., on-chip amplification). One of the most largely utilized compounds for the
fabrication of the main chip structures is PDMS (polydimethylsiloxane), a mineral-organic
elastomer particularly useful because it is largely elastically deformable, optically clear,
inert, non-toxic, non-flammable and inexpensive. It can be utilized alone, but it is often
coupled with harder compounds, like glass or thermoplastic polymers, in layering the main
structure of the chip. Because thermoplastic polymers are easily workable and less expen-
sive than glass, several of them are very recurrent: PMMA (polymethylmethacrylate) is the
most used alone [26,54,61], but more often it is coupled with PDMS [29,42,45,46,51,60,73];
PC (polycarbonate) was utilized, for example, by Ritzi-Lehnert et al. [71], who developed
a PC cassette to be inserted into chip analyzers, by Hwang et al. [68], who developed
a microfluidic device composed of four layers of PC, PDMS and glass, and by other
authors [52,66]. Although less common, also PET (polyethylene terephthalate) and PS
(polystyrene) have been used [50,62]. A good overview of the materials utilized in microflu-
idic chip fabrication is provided by Ren, Zhou and Wu [80]. A material is preferable to
others for its cost-effective availability, optical properties, hardness or capacity of deforma-
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bility, but it must also assure compatibility with the chemicals used in the protocol. For
example, PDMS is not compatible with organic solvents; therefore, it should be excluded
when projecting a LOC for extractions requiring such reagents. A quite complete list of
chemical compatibilities has been provided by Ali et al. [7]. Advances and automation
in manufacturing chips allow the bonding together of the same or different polymers
into multi-layers as well as the creation of ports, chambers, channels, filters, sites for the
addition of modules, etc. Even the smallest components of the fluidic system (valves,
micropumps, micromixers, etc.) can be made of such materials. Some examples are shown
with the chips described by Chen et al. [42] and Hwang et al. [68]: in the first study, they
etched a part of the main silicon microchannel producing micropillars with the function
of a weir-type filtration barrier to retain white blood cells and discard unwanted blood
components; in the second study they used a flexible PDMS membrane capable of varying
the volume of a microchamber upon occurrence.
While microchannels make up the circuit that transports the sample, the flux within
LOCs is enabled and modulated by a motion system. In most of the cases (see Table 1),
pressure-driven motion is implemented, where flux is usually sustained by external pumps
(syringe pumps or pressure-driven micropumps). Depending on the specific microdevice,
they allow sample or reagents circulation at an appropriate, controlled speed. Typically,
the starting raw or lysed sample is pumped into the chip at a flow rate ranging between
3 and 7 µL/min, allowing NA to come in contact with the capture matrix. Most of the
devices maintain constant flow rate during the whole process, while others modulate
access of diverse reagents at different flow rates [9,42,45,52,67,72,77]. Shaw et al. [65] use
an electro-osmotic pump operated by an external electric field (100 V/cm) through carbon
electrodes positioned upon the inlet holes of each microchannel. Han et al. [26] implement
a microfluidic system based on spiral micromixers generated by the operator when pushing
different reagents reservoirs. This produces transverse vortex phenomena that self-mix
flowing reagents. A first reservoir contains a mix of a lysis and a DNA binding buffer;
a second reservoir contains PBS for washing and purification steps; a third contains the
elution buffer. Also Jin et al. [58] take advantage of the microvortices generation. They
developed a powerless platform with a microchannel that connects thirty-five microwells in
series, where the continuous change of cross-sectional area of the flow is able to guarantee
an efficient mixing with microvortices.
Another usual approach for enabling motion inside LOCs is represented by magnetic
transportation: a movable or a permanent magnet transfers magnetic elements across the
microfluidic circuit. Most of the time, magnetic elements are coated with functional groups
capable of capturing NA by physical or chemical adsorption and enabling their transfer
into collection chambers [30,73]. Sometimes, this strategy is adopted for collecting and
removing cell debris [23] or for selectively binding a target (through specific antibodies),
for example, for pathogen detection [41]. Magnetic beads appear to be the most versatile
and rapid strategy for NA extraction (Table 1). This approach is extremely effective, but
inherently more expensive.
An interesting scenario where electro-magnetic field is employed is represented by
digital microfluidic platforms (DMF), which are based on electrical field modulation for
the manipulation of liquid samples in the form of droplets extremely small in size [81,82].
This approach enables the implementation of droplet-based microdevices where, starting
from sample, individual droplets are continuously formed and manipulated through the
microchannels, or where a variable number of droplets of each reagent are manipulated
and continuously moved upon a pathway of transportation electrodes (Figure 3).
This last case is described in a recent study [22]: electrical and magnetic forces are gen-
erated to move and split droplets over the cartridge; the sequence of activation of electrodes
and the activation of the magnet represent the automation of this type of microdevices.
NA bound to magnetic beads are collected on one side of the droplet, and the separation
electrode splits the whole droplet into a minor residual droplet (containing NA which will
be eluted) and a major supernatant droplet (containing unbound reagents, which will be
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washed away). DMF platforms have also been effectively tested for RNA extraction from
whole blood [57].
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Buffer, WB = Washing Buffer, EB = Elution Buffer) by droplet generation electrodes. Each droplet is controlled in its path by
voltage application on all the transportation electrodes.
Other interesting platforms for NA extraction are represented by centrifugal-driven
LOCs (or labs-on-a-disk, LODs), usually coupled with magnetic beads (details in Figure 4),
electrokinetic-driven LOCs [32,65], relying on voltage application for motion by electrical
gradient, and lab-on-a-paper devices, also implemented for NA extraction [40,55,56]. A
recent and cost-effective innovation is microfluidic origami [83]; it is a new branch of
microfluidic technology where paper can be exploited as an attractive and inexpensive
platform for NA extraction [40,84] due to its intrinsic advantages such as biocompatibility,
high surface area, and absorptive nature [85].
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2.2. Raw Samples Pre-Treatment
The first step for a successful NA extraction consists in the effective disruption of the
cell. When cells are part of raw tissues (such as stools or solid tissues), the sample needs
to undergo a complex pre-treatment (removal of solid impurities, homogenization, etc.)
before proceeding with membrane lysis. Membrane lysis methods can be categorized as:
(1) mechanical—by grinding, freeze-thawing, potterization, centrifugation, sonication or
bead-beating; (2) chemical—by detergents, solubilizing membrane lipids, or by chaotropic
agents, perforating cell membranes with the denaturation of trans-membrane proteins, by
enzymatic digestion, or by osmotic shock; (3) thermal—heating treatments; or (4) electrical
(by membrane dielectric breakdown) [14,87,88]. Sample lysis can be accomplished by
a single or a combined use of the above-mentioned methods, according to the type of
cell to treat and, eventually, according to the needed quality or yields of the extraction.
Specific nucleases can then be utilized to isolate the target NA (to obtain either RNA-free
DNA or DNA-free RNA). Finally, removal of contaminants must be performed. A list
of proposed approaches for on-chip raw sample pre-processing enabled by diverse LOC
strategies is reported in Table 2. Additional details for off-chip pre-processing are reported
in Supplementary Materials (Table S1).
Vortexing has been considered comparable to mixing by repetitive pipetting. Serum
and plasma separation has been demonstrated to be processable in microfluidic formats and
therefore integrable into existing LOCs [64,89–92]. For this reason, these tissues—although
they cannot be defined raw samples—are considered in the present review.
The most used methods for sample pre-processing are chemical, while thermal and
mechanical (such as filtering, agitation and pressing) approaches are rarer, and usually
applied to lyse bacteria or complex samples such as stools. Common reagents involved in
pre-processing include buffers and salts to stabilize pH during lysis, detergents to dissolve
cell membranes, and chelating agents which bind to metal ions with two positive charges
(e.g., magnesium and calcium) to reduce the level of some enzyme activity such as DNases.
When aiming at preserving just the RNA portion after total NA capture, Deoxyribonuclease
I (DNase I)—an enzyme able to catalyze the hydrolytic cleavage of phosphodiester linkages
in the DNA backbone, inducing DNA degradation—is often added in solution together
with lysis buffer [58]. In most on-chip lyses, reagents needed for DNA extraction are
administered manually by the operator, before running the process, through side inlet
ports or by filling suitable chambers. In advanced architectures, reagents are pre-loaded
on-chip. For example, reagents can be encapsulated in low-melting temperature agarose
gel and pre-loaded in the respective microchannels and chambers [65], loaded previously,
by connecting reagent tubes to the microfluidic system [27], or they can be contained in
deformable pouches fabricated into the chip, where depressing the pouch (snap-through)
squeezes liquid into the channel [66].
2.3. NA Isolation
For NA purification, whose ultimate goal is to remove the interferents from the
analyte, producing a solution containing principally the NA portion can be achieved
through different approaches [15].
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Table 2. Pre-treatment procedures applied to different sample types and in diverse LOC strategies. In details: guani-
dinium salts, principally GuHCl (Guanidine hydrochloride) and GuSCN (Guanidine thiocyanate), are the most used
chaotropic agents with the capacity of solubilizing proteins. Octylphenolethoxylate, commonly known as Triton-X100,
is a surfactant used to extract and release the cellular content due to its reactivity with lipid membrane bilayer. DDT
(Dithiothreitol) is primarily used to reduce disulphide bonds and, for example, deprotect thiolated DNA (sperm cells)
or denature protein structures. Proteinase K is an enzyme used to digest protein contaminants and inactivate nucleases.
Tris (tris(hydroxymethyl)aminomethane) is able to maintain pH of the buffer at a stable point, usually 8.0, and to interact
with lipopolysaccharides of the membrane, destabilizing it; EDTA (ethylenediaminetetraacetic acid) is a chelating agent
which binds to metal ions (e.g., magnesium and calcium), making them unavailable for other reactions such as those related
to DNases activity, or breaking Gram-negative bacteria walls. SDS (sodium dodecyl sulphate) is a protein denaturing
detergent. CTAB (cetyltrimethylammonium bromide) solubilizes membrane lipids and promotes cell lysis. Lysozyme is an
antimicrobial enzyme able to break thick peptidoglycan structures and lyse Gram-positive bacteria, useful when aiming at
infection detections. NaOH is used to perform alkaline lysis of membranes by the saponification of lipids. RNases catalyze
RNA degradation. SV = Sample volume; BV = Buffer volume.
ON-CHIP SAMPLE PREPARATION
CHEMICAL LYSIS
Sample Type SV BV Reagents Ref.
Whole blood
90 nL n.a. Sample droplet electrokinetically moved, mixed in a loop motion andincubated with Proteinase K and lysis buffer (details n.a.) [22]
1 µL 100 µL
Sample directly pipetted onto the extraction membrane. Water (200 µL) is
aspirated over the sample and the membrane by the syringe pump. 10 mM
NaOH (100 µL) is loaded into the extraction chamber and incubated for 5 min.
1 mM HCl (50 µL) is loaded to neutralize pH after lysis
[29]
10 µL 50 µL Sample and lysis buffer (4 M GuSCN in TE; 1% Triton X-100; pH 6.7)simultaneously pumped from two inlet holes into the microchannel [31]
200 µL n.a. Sample mixed with lysis buffer, RNase-A, binding buffer (details n.a.) [35]
0.5 µL 50 µL
Sample mixed into the reaction chamber with a lysis buffer solution (0.1%
CTAB, 1.5 M NaCl, MES, pH 5.0) and incubated for 15 min at
room temperature
[46]
4 µL 5.6 µL Sample is diluted with PBS (if the blood is old), mixed with lysis buffer(5.6 µL), and incubated for 5 min [49]
Plasma 140 µL 500 µL
Sample, DMP, lysis buffer (100 nM TrisHCl pH 8, 10 nM EDTA, 1% SDS, 10%




100 µL 200 µL Sample mixed with the cell lysis solution (Proteinase K and GuSCN-basedlysis buffer) [67]
100 µL 100 µL Sample mixed with pre-stored lysis and binding buffer (GuHCl-based) [68]
500 µL 100 µL
Sample pipetted into loading chamber. Water (200 µL) is aspirated over the
sample and the membrane by the syringe pump. 10mM NaOH (100 µL) is
loaded into the extraction chamber and incubated for 5 min. 1 mM HCl (50 µL)




Swab is placed into loading chamber. Water (200 µL) is aspirated over the
sample and the membrane by the syringe pump. 10 mM NaOH (100 µL) is
loaded into the extraction chamber and incubated for 5 min. 1 mM HCl (50 µL)
is loaded to neutralize pH after lysis
20 µL Swab incubated into the lysis solution (5 M GuHCl in 10 mM TE) at roomtemperature for 10 min [65]







Lysis for DNA extraction: semen (2 µL) diluted 1:1 with water, mixed with
lysis buffer (496 µL, 6 M GuHCl with 40 mM DDT, pH 6.1)
Lysis for RNA extraction: neat semen (20 µL) mixed with lysis buffer (480 µL,
6 M GuHCl with 40 mM DDT, pH 6.1)
[9]
1 µL n.a. Sample loaded and mixed with lysis buffer (6 M GuHCl with 4 mM DDT) [24]
Urine 50 µL 155 µL Sample mixed with a lysis-binding solution containing a GuHCl-based lysisbuffer (AL buffer, Qiagen), Proteinase K and DMA binding agent [26]
Stool 400 µL Liquid stool (diluted in water) mixed with pre-charged guanidine solid salts(reconstituting to 5 M GuHCl) and incubated for 5 min [73]
MECHANICAL + CHEMICAL LYSIS
Sample type SV BV Mechanical step Reagents Ref.
Hematuria
urine 100 µL 100 µL
Solution is pressure-forced (150 psi)
through small pores polymer
monolith
Sample is mixed with lysis solution
containing Proteinase K (0.8 mg/mL),
GuSCN and SDS (0.01%)
[75]
Whole blood,
Urine 2–10 µL n.a. Filtration
Sample is mixed with Proteinase K
and AL Buffer, Qiagen [52]
Whole blood 1 µL n.a.
Sample is premixed with PBS by the
micromixer to adjust viscosity of the
circulating solution. Sample flows
through a pillar filtering structure of
3 µm. spacing, which retains white
blood cells (6–9 µm. diameter) and
lets other blood components
pass through
Collected white blood cells are mixed
with 6 M GuHCl [39]
Nasal swab 1 mL
Swab is priorly vortexed for 1 min to
detach cells. Solution is loaded and
the vibrating and flexible PDMS
valve makes beads collide and cells to
be captured, while providing a
strong mixing
NaOH (6 µL; 0.02 N) is loaded for
lysis [68]
Whole blood 5 µL 150 µL
Filtration with 3.5 µm. pores
structure to retain white blood cells
and discard plasma and red
blood cells
Blood in 0.9% NaCl (45 µL). Mixing
white blood cells with loading buffer




swab 100 µL 600 µL
Mixing occurs by air
bubble insufflation
Sample is mixed with pre-treatment
buffer (300 µL; PBS and Lysozyme)
and with a GuSCN-based lysis buffer
(300 µL). Incubated at room
temperature for 3 min
[72]
Whole blood,
serum, plasma 200 µL 600 µL300 µL
Constant mixing is provided by the
control of rotational frequency
Sample is loaded with a lysis solution
(600 µL; GuSCN or AL Buffer, Qiagen,
Triton X-100, EDTA) or a
GuHCl-based lysis buffer (300 µL; AL
Buffer, Qiagen). Sample is incubated
with lysis solutions for 15 min at
room temperature
[28,64]
MECHANICAL + THERMAL LYSIS
Sample type SV Mechanical step Thermal step Ref.
Serum 0.4 µL Agitation
Irradiation (40 s) of the vibrating
chamber with laser beam (808 nm) for
heat shock
[23]
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CHEMICAL + THERMAL LYSIS
Sample type SV BV Reagents Thermal step Ref.
Nasopharyngeal
swab 500 µL 500 µL
Sample is mixed with lysis buffer
(500 µL; ML Buffer, Qiagen) and
Proteinase K
Lysis chamber is heated with a
resistive heater [71]
Whole blood 1 µL 14 µL
Sample is mixed with
lysis-electrolytic buffer (13 µL; 50 mM
Tris, pH 8.2; 50 mN HEPES, 1 µL of
Proteinase K)
Heating for 3 min with an on-chip
resistive heater [32]
THERMAL + MECHANICAL + CHEMICAL LYSIS
Sample type SV BV Thermal and mechanical steps Reagents Ref.
Whole blood 5.4 µL 5.8 µL Chip heated and agitated by amagnet (56 ◦C for 6 min)
Sample is mixed with lysis buffer
(5.4 µL, details n.a.) and Proteinase K
(0.4 µL).
[34]
Whole blood 300 µL 330 µL
Heating with a thermoelectric heater
(56 ◦C for 10 min). Mixing with an air
bubble blow from the bottom of
the chamber
Sample is mixed with Proteinase K
(30 µL) and lysis buffer (300 µL; AL
Buffer, Qiagen)
[36]
Stool 200 mg n.a.
Sample is heated (90 ◦C for 5 min)
and homogenized by a small
vibrating magnet. Homogenate
mixed by air bubble insufflation and
filtered by a 1 µm. pore-size filter to
remove fecal impurities
Lysis reagents (details n.a.) are mixed
with sample by air
pressure application.
[27]
Traditional methods consist of precipitation. In these conventional, widely adopted
approaches, cells are lysed, and cell debris is usually removed by centrifugation. In the
most used strategy, phase separation is obtained by mixing a solution of organic solvents
(typically containing phenol, chloroform and a chaotropic agent, often GuSCN) with the
aqueous sample, followed by centrifugation [91,93]. Such reagents are effective in re-
moving proteins, lipids and detergents from the solution, allowing their dissolution or
accumulation at the aqueous interface by centrifugation. In particular, GuSCN denatures
proteins and RNases; chloroform forms a colorless upper aqueous phase containing RNA,
an interphase containing DNA and a lower phenol-chloroform phase containing proteins.
NA can be collected from the upper aqueous phase by alcohol (isopropanol or ethanol)
precipitation followed by rehydration [7]. Among precipitation methods, salting-out tech-
niques are also often used—based on the exploitation of high concentrations of potassium
or ammonium acetate—to allow the removal of contaminants, such as proteins and other
biomolecules [15,94]. Although sufficiently effective, these approaches present several
drawbacks which make them hard to be implemented on LOCs and POC tests. In fact,
they are time-consuming, rely on intensive manual processing, employ hazardous reagents,
potentially damaging equipment [95] and, in addition, residual phenol or chloroform may
affect downstream applications such as PCR.
Another class of NA extraction methods is liquid–liquid extraction (LLE), based on
the manipulation of aqueous pH to extract NA into an organic solvent. Knowledge of
the chemical properties of biological specimens allows proper selection of the organic
solvent, which is the main factor for successful isolation and purification processes [15,94].
Typical organic solutions and/or detergents for sample washing are phenol, chloroform,
or cetyltrimethylammonium bromide. Although widely used for a long time, and best
performing on samples with very low NA concentrations, LLE suffers from several dis-
advantages, which make these methods not easily implementable on LOCs. Limitations
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include time-consumption, presence of non-automatable steps, usage of organic solvents
(which are toxic and costly), and need of expensive glassware.
2.3.1. Solid-Phase Extraction
More recent approaches overcome drawbacks of precipitation and LLE in on-chip NA
extraction. They are called solid-phase extraction (SPE) methods. SPE involves the use of a
solid material able to selectively separate the target analyte from the solution, followed by a
release mechanism. This approach utilizes chemical and physical properties (i.e., hydropho-
bic, polar, and/or ionic features) of the solutes dissolved or suspended in a liquid (also
known as the mobile phase) to separate them from undesired components when filtered
through an adsorbent (also known as the stationary phase). The strong chemistry between
the sorbent and the analyte of interest is at the basis of the sorption phase, while weak
chemical interactions, such as van der Waals forces (non-polar interactions), dipole–dipole
interactions (polar interactions) and hydrogen bonding modulate the retention/release
mechanism [7].
SPE in LOCs usually consists of concentrating and purifying analytes from solution
by adsorption onto a disposable solid-phase cartridge, followed by elution of the analyte
with an appropriate solvent. Adsorption is typically enabled by silica structures, ion-
exchange resins, or gels. The most utilized substrate for SPE is represented by silica-based
surfaces, which consist of silica material in form of either gel or glass particles, like glass
powders, microbeads, microfibers or even microstructures such as micropillars, monoliths
or membranes. The principle of silica matrices extraction is based on their exceptional
ability in binding DNA under specific salt conditions: modulating pH with a chaotropic
binding buffer, silanol groups gain a high affinity to the negative charged backbone of
DNA. Moreover, silica material is often covered of positive ions to enhance this affinity.
The presence of chaotropic salts at high concentration, coupled to organic solvents (such
as ethanol or isopropanol), aids protein denaturation but also facilitates binding of NA to
silica structures providing the optimal pH. It is worth to note that chaotropic salts (such as
GuSCN and GuHCl) can play a double role in NA extraction, acting both as a lysis agent
and being part of the binding buffer.
Different silica structures have been implemented in LOCs for NA extraction (Figure 5).
As an interesting example, Brassard et al. [36] utilize a double layer of glass microfiber
filters (composed of silica with sodium, potassium or calcium) where the first layer (2.7 µm.
pored) acts as a pre-filter for whole blood, while the second layer (0.7 µm. pored) acts as
the capture matrix. Whereas in most cases silica structures are composed of glass, also
tetraethyl-orthosilicate (TEOS) [24] and tetramethyl-orthosilicate (TMOS) [38,43] were used
as capture materials.
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Figure 5. Examples of most common ica structures invol ed in adsorbing NA: (A) pyramidal micropil ars [33]; (B) surfaces
packed with silica m robeads [9,10,38,44,68,76]; (C) colloidal s -gel solutions packed with silica microbeads [24,25,43];
(D) silica wafer monolith [31,39,42,65] or polymer monolith with silica microbe ds [69,75]; (E) silica membrane fil-
ters [29,47,53,55,56,59,72].
Because tr i elements can egatively interf re with downstream processes (such
as NA amplification, for which t ey act as strong inhibitors), altern tive SPE methods to a
standard silic phase were set up for NA extraction. They consist of using pH dependent
anio -exch ge approach s [45,96] or kosmotropic salts o induce acidic conditions [97] in
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order to foster NA binding to the solid phase. An example of a pH-controlled approach is
represented by chitosan-coated structures. This strategy promotes NA binding to—and
release from—the chitosan phase based on a change in buffer pH. Chitosan is a polymer
with a high number of amine groups, which presents a cationic charge at pH 5; but it is
easily neutralized at pH 9: this property has been shown to be effective for DNA extraction
at pH 5 and its release from chitosan at pH 9 [45]. Moreover, low-molecular weight
chitosan is a proven inhibitor of RNases, demonstrating the advantages of chitosan as a
solid phase for RNA purification compared to silica [10]. A recent study by Gan et al. [46]
showed a chitosan-coated version of the Fusion 5 filter. In this version of the platform,
DNA extraction is due to both the entanglement of the long-chain DNA molecules on
the filter weave, made of glass fibers bonded with organic binders, and the electrostatic
adsorption to the chitosan polymer, which keeps the DNA bound even at high pH (useful
feature for successive on-chip amplification, which requires a pH increase). Around pH
5, DNA molecules are “actively” adsorbed onto the chitosan-modified fibers. Once DNA
is adsorbed, the physical entanglement of the long-chain molecules with the fiber matrix
can also assist the capture. At pH 9, although DNA is not “actively” absorbed onto the
fibers, DNA molecules remain bound due to the physical trapping of these long-chain
DNA molecules within the fiber matrix against washing and elution.
Another variety of SPE techniques for NA is based on electrostatic or covalent in-
teractions between DNA and surfaces modified through amine coatings. Amine groups
below neutral pH have a positive charge (causing negatively charged DNA to bind), which
decreases above neutral pH [14]. An example is represented by Shin [52] and Han et al. [26],
who use DMA (dimethyl-adipimidate), a non-chaotropic reagent able to bind fragmented
DNA to its amino groups, and APTES (3-aminopropyl-triethoxysilane)-coated glass, which
captures DNA/DMA complexes. Using the same amino-silanized surface as capture ma-
trix, DMP (dimethyl-pimelimidate) is used as an alternative to DMA, for NA extraction,
thanks to its ability of creating complexes with NA by covalent bonds of the amino groups
of DMP molecules [58].
Electrostatic interactions were sometimes coupled to nanoporous membrane filtration,
obtained for example through mid-sized pores in aluminum oxide membrane [98], to
improve NA extraction, as in the case of Kim and Gale [37], who developed a microfluidic
system for DNA capture relying on an aluminum oxide membrane with 100 nm pores size.
Electrostatic attraction between DNA and alumina causes it to adsorb to the membrane,
while other components flow into the waste chamber.
2.3.2. Magnetic Particles
Often, magnetic particles, or beads, have been coupled to suitable buffer systems
for rapid and efficient NA extraction. Their use is rapid, simple to perform and can
be automated, although more expensive than other methodologies. Magnetic particles
work on the principle of complementary hybridization and are composed of a magnetic
core, such as magnetite (Fe3O4) or maghemite (Fe2O3), usually coated with a matrix of
polymers, silica, or hydroxyapatite with terminal functionalized groups to enable NA
capture. The most recurrent covalent functionalizations of magnetic beads are carboxy-,
amino-, hydroxy-, thio- terminations of the coated surface, while the non-covalent ones
are represented by bioactivated coatings (peptides, aptamers, biotin, streptavidin, etc.) or
rely on hydrophobic interactions [99]. The method is based on the principle that NA can
reversibly bind the solid surface, previously coated with NA binding antibodies, aptamers,
or with functional groups that interact specifically with DNA. The reversible complexation
of beads with nucleic acids is controlled by adjusting the pH or the salt concentration [100].
For LOC devices, the advantage of using magnetic particles is that they can be used free
floating in solution, thereby maximizing the interaction between sample and beads, and
then collected in a microchannel or a microchamber using a magnetic field, rather than by
centrifugation or filtration.
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Magnetic beads (Figure 6) represent the most commonly adopted strategy for NA
extraction. After binding, beads are separated from contaminating cellular components,
washed, and exposed to ethanol to obtain a purified DNA elution [101]. The majority of
LOCs based on a magnetic beads NA extraction utilize beads with silica coatings (Table 1);
they are added and mixed to sample and lysis buffers [28,49–51,54,60,61,63,64,67,70,71,73].
After cell lysis, DNA-bound beads are driven and collected by a magnetic coil, while the
unbound debris is removed by a stream of washing buffers. Some approaches couple
magnetic field with heating to improve the whole process [27]. For example, Lee et al. [23]
describe a compact device based on a laser-irradiated magnetic beads system (LIMBS).
It is equipped with carboxylic acid-terminated polystyrene magnetic beads, involved
in heat transfer and cell debris adsorption, and operates with a laser-beam irradiation
(1 W for 40 s), able to heat magnetic beads. The continuous vibration occurring on the
chip by means of a motor is responsible for beads collision with the cellular targets,
enabling heat transfer to them. The combination of heat shock and mechanical agitation
breaks membranes, making cells release nucleic acids in solution. Functional groups on
the polystyrene surface of the magnetic beads have the capacity to adsorb most of PCR
inhibitors, like denatured proteins and cell debris, which are removed by capture of beads
with a permanent magnet. Another interesting strategy is presented by Lien et al. [35],
who exploit a double step of magnetic beads usage in DNA extraction from whole blood:
antibody-labeled leukocyte-specific magnetic beads, for enabling leukocytes separation,
and a second type of magnetic beads (charge-switchable), able to switch charge by pH
variations to bind/unbind DNA molecules.
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igure 6. Magnetic beads can be magnetically manipulated because of their ir n core and—with their
activated coatings, such as functional groups or specific antibodies—can interact and selectively bind
a desired ligand. The most recurrent functionalization for NA extraction is the silica-coating. If the
target is human mRNA, the easiest choice is magnetic beads coated ith oligo-dT probes [48]. When
aiming only at a patho en detecti n, functionalization with target specific antibodies is used [41],
although this falls outside the aims of the review, devoted to total NA purification.
.3.3. Other Approaches
Although arely, other materials different from silica nano- r mi ro-structures or
agnetic-based components were used for SPE. As capture matrix, Huang et al. [74]
utilize a porous polymer monolith SPE-column composed of ethylene dimethacrylate
(EDMA, as crosslinker), butyl-methacrylate (BUMA), 1-dodecanol (as porogenic solvent),
azobisisobutyro-nitrile (AIBN, as polymerization initiator). Differently from traditional
SPEs—which exploit particle-based adsorbents—polymer monoliths, which are solid pieces
of stationary phase, present bimodal structures: macropores enable passage of solvent
while mesopores separate analytes. These methods assure separation capabilities similar to
those of particle-based adsorbents, increasing sample throughput, reducing solvent usage,
and being suitable for automation [102]. Another example is described by Choi et al. [62]
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who present the functional coating of a polycarbonate chip with an adsorbing surface made
of a DMAMS (poly-2-dimethylaminomethyl-styrene) polymer. Such material is positively
charged, so it has the capacity to electrostatically attract the negative phosphate backbone
of DNA. Finally, strategies different from SPE were also adopted to extract DNA on LOCs,
for example those relying on isotachophoresis [32].
2.4. Additional Considerations on RNA Isolation
Specific considerations can be associated to RNA extraction. When working with
RNA, chemical differences with DNA must be considered. In fact, RNA is very different
from DNA in terms of chemical stability. The single –OH group difference makes the ribose
sugar much more chemically reactive than deoxyribose. Additionally, RNases, a class
of RNA degrading enzymes ubiquitous and robust, can rapidly destroy RNA molecules.
Due to RNA fragility, a reverse transcription phase to complementary DNA (cDNA) is
necessary in order to stabilize molecules and allow further processing after extraction.
RNA is more closely related to proteins than DNA, so it is able to describe a scenario
tightly connected to the actual cellular machinery. Nevertheless, whereas a large number
of LOCs were developed for DNA extraction, microfluidic systems dedicated to RNA
purification are relatively rare in literature. This is probably due to its high instability and
susceptibility to degradation, thus requiring special care and precaution during isolation
and processing. Moreover, due to affinity of many matrices (such as the silica ones) for
both DNA and RNA, most of the extraction systems finely tuned for DNA also bind RNA,
thus reducing the need for RNA dedicated solutions.
In these systems, both NA types are isolated from the same biological sample at
the same time, and extraction specificity is usually assured by the endonuclease activity
of either DNase I or RNase A modulating their action to recover either RNA or DNA,
respectively. Strong denaturants are typically used in intact RNA isolation to inhibit
endogenous RNases, which are heat-stable and refold following heat denaturation [11].
Reedy et al. [9] perform both DNA and RNA extractions with their LOC, and, when
only RNA was needed, DNA was digested at the end of the extraction process. Also Ha-
gan et al. [10] digest DNA at the end of the extraction with a DNase. Nevertheless, in some
cases, specific protocols were implemented for RNA purification. Capture of eukaryotic
mRNA, which is clearly characterized by a poly-A tail (a sequence of polyadenylic acid
at the 3′ terminus), has been performed exploiting magnetic beads coated with oligo-dTs.
Additionally, Han et al. [14], who perform mRNA extraction and cDNA synthesis on the
same device, utilize oligo-dT magnetic beads, which here are led to the elution chamber
by taking advantage of lateral magnetophoresis technique. Another example of poly-T
functionalization is described by Lee et al. [48] in their lateral magnetophoresis mRNA
microextractor, and also by Satterfield et al. [103] with the surface of a methacrylate-based
porous polymer monolith (PPM) functionalized with 20-mer oligo-dT.
When the chip included a PCR module or the RNA target was immediately amplified
by off-chip PCR, as it is common for viral RNA detection in human specimens, generally
both nucleic acids are extracted together with no need of endonuclease digestion.
2.5. Post-Processing
NA purification on LOCs can be achieved using either of the two following strategies:
selectively binding NA to the adsorbent matrices while washing out, usually with a
nonpolar solvent, the rest of cell components and other chemicals, and further eluting NA
with appropriate solvent for recovery; or not retaining NA, while capturing all components
to discard [23]. The first approach is the most exploited.
A washing buffer is used to remove non-nucleic acid organic (i.e., proteins, lipids)
and inorganic molecules (i.e., unbound components, residual detergents, lysing salts) from
resultant extracts. This phase usually consists of washing the NA-adsorbed surface with a
slow, controlled flow of propanol, generally applied for 15 min, and in collecting wastes
into a dedicated chamber or through an outlet port. Sometimes ethanol or ethanol-based
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buffers are preferred to propanol (Table 3). In some LOCs, there is a unique washing step;
in other cases, there is a pre-wash phase with alcoholic mixed salt buffers and a main
washing step with an alcoholic buffer. Less commonly, in some specific cases with magnetic
beads [73], samples can be washed by forcing their passage through an immiscible washing
oil phase capable of blocking molecules to discard. In some implementations, protein
separation is performed before NA capturing, using protein-capture columns [38].
Analogously to the other chemicals and independently of the chosen washing strategy,
in most cases, the washing buffer is injected by syringe pumps or is pre-stored on-chip in
dedicated chambers, which are activated by pressure application or by valve opening at
the correct time during the purification protocol. In some implementations, vice versa—the
sample is moved into the chamber containing the washing buffer. As a consequence of
washing, lysed biomolecules (such as proteins, metabolites, membrane lipids, etc.), lysing
detergents and any buffers used to adjust pH conditions are removed, and NA molecules
remain bound to the adsorbent substrate. To be released from the capture matrix, NA must
come in contact with a low ionic strength buffer, whose pH is adequate to dissolve the
bonding. The elution buffer collects NA and leads it to the desired region, to gather it or
for subsequent on-chip detection aims.
















Elution strictly depends on the pH of the solution, which enables or disables binding,
and it also directly depends on the used capture matrix. DNA elution from silica matrix
is performed by a hypo-osmotic solution, typically a low salt buffer or elution buffer,
generally alkaline. A common NA elution consists in flowing pH = 8 TE buffer (Tris-
EDTA). Chitosan has a cationic charge which is easily neutralized at pH = 8.5/9; therefore,
NA elution from this matrix is commonly obtained by using pH = 9 TrisKCl [9,45]; the
same buffer is used when eluting from aluminum oxide membranes because it showed
better extraction efficiencies [37]. The same buffers are used for elution from silica-coated
magnetic beads. Other alkaline eluents are utilized, for example NaOH or NaHCO3, but,
even though a higher pH yields a more concentrated extraction, water is always widely
used. In sample-in answer-out devices, where an amplification occurs after NA extraction,
elution is performed directly into the PCR mix. Elution flow rates can vary significantly,
depending on the microchannel section and the matrix composition, from a higher rate
of 500 µL/min [68] to a slower rate of 1 µL/min [45]. It is worth to note that the elution
volume represents a critical issue; in fact, while volume reduction is an advantage in terms
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of costs and wastes reduction, it can be troublesome for pipetting away small NA quantities
in minimal elution volumes. To overcome this issue, an over-dilution step of the final eluate
could be considered (e.g., Lee et al., 2020 [49]), or parallel extractions from the same raw
sample should be enabled when designing the chip.
3. NA Applications for Medical Diagnostics
As final validation, many LOCs are tested for the application in different molecular
diagnostic fields to clarify patients’ genetic anomalies or occurring infections caused by
pathogens, such as bacteria, DNA viruses, parasites, etc. The extraction step is crucially
important because NA quality influences the success of further analyses. Many LOCs have
been coupled to DNA detection methods, usually performing both steps online, relying
on amplification to identify the unique sequences of specific invading pathogens within
human samples. Rapid and comfortable (possibly run ‘at the time and place of patient
care’) identification of infectious diseases can reduce further treatment costs and patient
sufferings, and can contain disease spreading among the population. LOCs were fruitfully
applied to detect many different pathogens from different raw sample types (Table 4).
Table 4. List of pathogens detected with the described LOC.
Specimens NA Pathogens Reference
Blood
DNA
Hepatitis B virus [23,41,54,55,60,61]




Staphylococcus warneri, Streptococcus agalactiae, Haemophilus influenzae [64]
RNA
Rift Valley fever virus [28]
Human immunodeficiency virus [40,61]
SFTS virus [58]










Human immunodeficiency virus [66]
Parainfluenza virus, Rhinovirus A, Metapneumovirus [30]
Respiratory-syncytial virus [30,70]









RNA Human Enterovirus 71 [27]
Spinal fluids DNA Herpes simplex virus, Varicella zoster virus [43]
Sensors 2021, 21, 3058 21 of 27
Although more often used for detection of proteins, metabolites or other small molecules,
extraction LOCs can also be helpful in genetic disease detection [104], usually performed
through DNA offline extraction followed by sequencing or genotyping approaches. More
recently, LOCs were designed to capture circulating cell-free DNA (ccfDNA) from serum
samples of cancer patients [105–107]: ccfDNA capture requires increased ability in adsorb-
ing short fragments, thus implying customized isolation strategies [19]. Another interesting
application of DNA extracted with LOCs is represented by forensic evaluations, especially
when available sample volumes are extremely low [9,24,29,75]. While DNA extraction
represents the basis for analyses regarding human genotype and for most of the infections
caused by pathogens, RNA extraction enables procedures to shed light on the phenotypic
layer of the organism, interesting to identify either pathological or specific physiological
conditions detectable at the transcription level. Moreover, RNA extraction was exploited on
LOCs for the detection of RNA viruses infecting human organism (Table 4).
The recent COVID-19 pandemic has increased the need for rapid diagnoses to isolate
infected population and, moreover, the need for rapid and easy-to-use devices for an
effective screening of population and contact tracing of infected patients. This scenario has
meant that the world of miniaturized devices was prepared to offer its own alternatives
to the labor-intensive traditional RT-qPCR. A not-exhaustive list of already-validated
LOCs for SARS-CoV-2 detection [108] is presented in Table 5. Generally, these devices,
considered more as POC tests, rely on total NA extraction followed by RT-qPCR, performed
on pre-filled cartridges or cartridges to fill with a kit of reagents for a complete processing.
Table 5. List of patented and authorized POC for SARS-CoV-2 detection.
COVID-19 POC Test Sample Time LoD Reference
Xpert Xpress 300 µL 45 min 100 copies/mL [109–111]
ePlex 200 µL 90 min 1000 copies/mL [110]
Novodiag 250 µL 75 min 313 copies/mL [111]
ID NOW 200 µL 13 min 125 copies/mL [112]
Accula Test 10 µL 30 min 200 copies/mL [113,114]
FilmArray 300 µL 60 min 330 copies/mL [115]
Vivalytic 300 µL 39 min n.a. [116]
4. Conclusions
The present review aims at describing the strategies adopted in the literature to
extract NA from raw human samples. Most LOCs were developed for genomic DNA
extraction only, generally addressed to a subsequent off-device PCR analysis with bench
thermocyclers, although RNA or total NA extraction are also described, often coupled with
a detection domain. Diverse microfluidic solutions have been analyzed, differing in the
starting raw sample, the shapes of the fluidic path, the motion strategy of analytes and
reagents, the adsorbent structures, the methods for eluate and wastes collection, or the
further on-chip detection. For each phase, LOC developers have to choose among a plethora
of possible solutions, potentially considering intrinsic issues to take care. For example,
the adsorption capacity of the chemical composition of the chip should be considered to
avoid non-specific capture. A quite common case is represented by PDMS channels, which
can adsorb biomolecules onto the walls [80]. To avoid this, several strategies have been
proposed, such as plasma treatment, surface coating with organosilanes, or other types
of functionalization. Nevertheless, most of the analyzed LOCs demonstrated extraction
efficiencies similar to commercial kits, thus demonstrating that these kinds of drawbacks
are relevant only when dealing with very little concentrated targets (e.g., ccfDNA, rare
RNA transcripts, or low bacterial/viral presence).
The extraction strategies most compatible with LOC miniaturization are SPE methods
relying on silica adsorbent matrices of various shape, layering, chemical composition and
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filtering capacity. SPE approaches are very efficient, although they need high volumes of
reagents to bind, wash and efficiently elute. NA. Moreover, the release of shorter fragments
during the elution phase could represent a difficult step when using silica matrices [7,50].
The obstruction of the extraction matrix, especially when whole blood is used, should be
avoided by an effective pre-treatment of the sample or by specific flow control strategies
(e.g., crossflow filtration [42]). Silica matrices are often chosen as a capture method for NA
because they are easy to be integrated in miniaturized instruments, provide a high-purity
eluate, and are less expensive than other matrices. Conversely, magnetic beads are the
adsorbent matrix of choice in many other cases, especially in LODs, for their ease of usage,
high flow rate during the extraction compared to silica matrices [16], and because they
are versatile and can be coated with generic or specific functionalized layers to optimize
capture precision. Nevertheless, they represent an expensive solution and often require a
bulky electrical device or a unit capable of modulating magnetic field. Moreover, magnetic
beads tend to aggregate, a problem that can be avoided not exceeding in magnetic force
application or in motion/centrifugal speed.
LOCs for NA extraction are usually tested with whole blood samples because, on
the one hand, it is a challenging sample for the development of effective capture matrices,
but, on the other one, it is quite common and obtainable, commonly used for genomic
DNA extraction. Other kinds of samples, such as nasal washes, aspirates, swabs or stool
are mostly processed for total NA extraction in LOCs devoted to pathogens detection.
Ideally, it would be possible to use the same LOC to obtain NA from various types of raw
samples, adapting the pre-treatment step to adequately free NA in solution. It is therefore
of paramount importance to adopt lysis protocols suitable for the specific sample.
Typically, a nucleic acid extraction performed with traditional kits and laboratory
equipment can last from about 20 min to 1–3 h [117–121], and expert operators and ex-
pensive facilities are required. Once optimized for accuracy, miniaturization, versatility
and automation, LOCs will overcome the disadvantages of traditional approaches. Indeed,
the main objective of LOCs is to obtain reliable results while dramatically simplifying the
entire process and reducing running time and needed volumes. These aspects would be
particularly appealing, for example, in the forensic context, where the amount of available
samples is often limited. Moreover, LOCs allow one to maximize experimental design,
overcoming the limiting factors related to running time and reagents consumption. Finally,
thanks to their compactness, portability and user-friendliness, LOCs allow the performance
of on-field analyses; instead of moving samples to the laboratory, it would be possible
to move the laboratory equipment to end-users, with a resulting significant reduction of
sample contamination and degradation. In this perspective, LOCs can foster the develop-
ment of POC tests, promoting and supporting personalized medicine, wide population
screening and telemedicine.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
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